Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2014

Open Access 01-06-2014 | Research article

The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout

Author: Jasvinder A Singh

Published in: Arthritis Research & Therapy | Issue 3/2014

Login to get access

Abstract

Introduction

The aim of this study was to examine the impact of gout on quality of life (QOL) and study differences by gender and race.

Methods

Ten race- and sex-stratified nominal groups were conducted, oversampling for African-Americans and women with gout. Patients presented, discussed, combined and rank-ordered their concerns.

Results

A total of 62 patients with mean age 65.1 years, 60% men, 64% African-American, participated in 10 nominal groups: African-American men (n = 23; 3 groups); African-American women (n = 18; 3 groups); Caucasian men (n = 15; 3 groups); and Caucasian women (n = 6; 1 group). The most frequently cited high-ranked concerns among the ten nominal groups were: (1) effect of gout flare on daily activities (n = 10 groups); (2) work disability (n = 8 groups); (3) severe pain (n = 8 groups); (4) joint swelling and tenderness (n = 6 groups); (5) food restrictions (n = 6 groups); (6) medication related issues (n = 6 groups); (7) dependency on family and others (n = 5 groups); (8) emotional Impact (n = 5 groups); (9) interference with sexual function (n = 4 groups); (10) difficulty with shoes (n = 4 groups); and (11) sleep disruption (n = 4 groups). Compared with men, women ranked the following concerns high more often: problems with shoes (n = 4 versus n = 0 groups); dependency (n = 3 versus n = 2 groups); and joint/limb deformity (n = 2 versus n = 0 group). Compared with Caucasians, African-Americans ranked the following concerns high more often: dietary restrictions (n = 6 versus n = 0 groups); severe pain (n = 6 versus n = 2 groups); gout bringing the day to a “halt” (n = 2 versus n = 0 group); effect on emotional health (n = 4 versus n = 1 groups); and the need for canes/crutches during flares (n = 2 versus n = 0 group).

Conclusions

Gout has a significant impact on a patient’s QOL. Important differences in the impact of gout by gender and race were noted.
Literature
1.
go back to reference Zhu Y, Pandya BJ, Choi HK: Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011, 63: 3136-3141. 10.1002/art.30520.CrossRefPubMed Zhu Y, Pandya BJ, Choi HK: Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011, 63: 3136-3141. 10.1002/art.30520.CrossRefPubMed
2.
3.
go back to reference Garg R, Sayles HR, Yu F, Michaud K, Singh J, Saag KG, Mikuls TR: Gout-related health care utilization in US emergency departments, 2006 through 2008. Arthritis Care Res (Hoboken). 2013, 65: 571-577. Epub 2012/09/06CrossRef Garg R, Sayles HR, Yu F, Michaud K, Singh J, Saag KG, Mikuls TR: Gout-related health care utilization in US emergency departments, 2006 through 2008. Arthritis Care Res (Hoboken). 2013, 65: 571-577. Epub 2012/09/06CrossRef
5.
go back to reference Singh JA, Hodges JS, Asch SM: Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis. 2009, 68: 1265-1270. 10.1136/ard.2008.092619.CrossRefPubMed Singh JA, Hodges JS, Asch SM: Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis. 2009, 68: 1265-1270. 10.1136/ard.2008.092619.CrossRefPubMed
6.
go back to reference Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS: Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 2009, 11: R46-10.1186/ar2659.PubMedCentralCrossRefPubMed Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS: Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 2009, 11: R46-10.1186/ar2659.PubMedCentralCrossRefPubMed
7.
go back to reference Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG: Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006, 65: 1368-1372. 10.1136/ard.2006.051649.PubMedCentralCrossRefPubMed Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG: Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006, 65: 1368-1372. 10.1136/ard.2006.051649.PubMedCentralCrossRefPubMed
8.
go back to reference Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG: Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford). 2005, 44: 1038-1042. 10.1093/rheumatology/keh679.CrossRef Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG: Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford). 2005, 44: 1038-1042. 10.1093/rheumatology/keh679.CrossRef
9.
go back to reference Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW: Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006, 81: 925-934. 10.4065/81.7.925.CrossRefPubMed Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW: Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006, 81: 925-934. 10.4065/81.7.925.CrossRefPubMed
10.
go back to reference Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW: Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol. 2006, 12: 61-65. 10.1097/01.rhu.0000209882.50228.9f.CrossRefPubMed Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW: Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol. 2006, 12: 61-65. 10.1097/01.rhu.0000209882.50228.9f.CrossRefPubMed
11.
go back to reference Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R: American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012. 2012, 64: 1431-1446.CrossRef Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R: American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012. 2012, 64: 1431-1446.CrossRef
12.
go back to reference Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentao J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gorska I: EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006, 65: 1312-1324. 10.1136/ard.2006.055269.PubMedCentralCrossRefPubMed Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentao J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gorska I: EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006, 65: 1312-1324. 10.1136/ard.2006.055269.PubMedCentralCrossRefPubMed
14.
go back to reference Krishnan E, Lienesch D, Kwoh CK: Gout in ambulatory care settings in the United States. J Rheumatol. 2008, 35: 498-501.PubMed Krishnan E, Lienesch D, Kwoh CK: Gout in ambulatory care settings in the United States. J Rheumatol. 2008, 35: 498-501.PubMed
15.
go back to reference Solomon DH, Avorn J, Levin R, Brookhart MA: Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis. 2008, 67: 609-613.CrossRefPubMed Solomon DH, Avorn J, Levin R, Brookhart MA: Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis. 2008, 67: 609-613.CrossRefPubMed
16.
go back to reference Harris CM, Lloyd DC, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995, 48: 1153-1158. 10.1016/0895-4356(94)00244-K.CrossRefPubMed Harris CM, Lloyd DC, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995, 48: 1153-1158. 10.1016/0895-4356(94)00244-K.CrossRefPubMed
17.
go back to reference Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, Horne A, Gamble G, McQueen FM, Taylor WJ: Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken). 2011, 63: 1605-1612. 10.1002/acr.20570.CrossRef Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, Horne A, Gamble G, McQueen FM, Taylor WJ: Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken). 2011, 63: 1605-1612. 10.1002/acr.20570.CrossRef
18.
go back to reference Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, Vietri J, Khanna D: Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes. 2012, 10: 117-10.1186/1477-7525-10-117.PubMedCentralCrossRefPubMed Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, Vietri J, Khanna D: Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes. 2012, 10: 117-10.1186/1477-7525-10-117.PubMedCentralCrossRefPubMed
19.
go back to reference Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, Kavanaugh A: Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009, 48: 582-586.CrossRef Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, Kavanaugh A: Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009, 48: 582-586.CrossRef
20.
go back to reference Roddy E, Zhang W, Doherty M: Is gout associated with reduced quality of life? A case–control study. Rheumatology (Oxford). 2007, 46: 1441-1444. 10.1093/rheumatology/kem150.CrossRef Roddy E, Zhang W, Doherty M: Is gout associated with reduced quality of life? A case–control study. Rheumatology (Oxford). 2007, 46: 1441-1444. 10.1093/rheumatology/kem150.CrossRef
21.
go back to reference Singh JA, Strand V: Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008, 67: 1310-1316.CrossRefPubMed Singh JA, Strand V: Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008, 67: 1310-1316.CrossRefPubMed
22.
go back to reference Khanna PP, Perez-Ruiz F, Maranian P, Khanna D: Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology (Oxford). 2011, 50: 740-745. 10.1093/rheumatology/keq346.CrossRef Khanna PP, Perez-Ruiz F, Maranian P, Khanna D: Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology (Oxford). 2011, 50: 740-745. 10.1093/rheumatology/keq346.CrossRef
23.
go back to reference Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW, Hamburger SA, Becker MA: Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011, 306: 711-720.CrossRefPubMed Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW, Hamburger SA, Becker MA: Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011, 306: 711-720.CrossRefPubMed
24.
go back to reference Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA: Patients and providers view gout differently: a qualitative study. Chronic Illn. 2010, 6: 263-271. 10.1177/1742395310378761.PubMedCentralCrossRefPubMed Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA: Patients and providers view gout differently: a qualitative study. Chronic Illn. 2010, 6: 263-271. 10.1177/1742395310378761.PubMedCentralCrossRefPubMed
25.
go back to reference Spencer K, Carr A, Doherty M: Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012, 71: 1490-1495. 10.1136/annrheumdis-2011-200801.CrossRefPubMed Spencer K, Carr A, Doherty M: Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012, 71: 1490-1495. 10.1136/annrheumdis-2011-200801.CrossRefPubMed
26.
go back to reference Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N: The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011, 17: 1-6. 10.1097/RHU.0b013e318204a8f9.CrossRefPubMed Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N: The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011, 17: 1-6. 10.1097/RHU.0b013e318204a8f9.CrossRefPubMed
27.
go back to reference Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum. 2008, 58: 15-25. 10.1002/art.23177.CrossRefPubMed Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum. 2008, 58: 15-25. 10.1002/art.23177.CrossRefPubMed
28.
go back to reference Corbin J, Strauss AL: Accompaniments of chronic illness: changes in body, self, biography, and biographical time. Research in the Sociology of Health Care: A Research Annual. Vol. 6. The Experience and Management of Chronic Illness Greenwich, Vol. 6. Edited by: Roth JA, Conrad P. 1987, Greenwich, CT: JAI Press, Inc, 249-281. Corbin J, Strauss AL: Accompaniments of chronic illness: changes in body, self, biography, and biographical time. Research in the Sociology of Health Care: A Research Annual. Vol. 6. The Experience and Management of Chronic Illness Greenwich, Vol. 6. Edited by: Roth JA, Conrad P. 1987, Greenwich, CT: JAI Press, Inc, 249-281.
29.
go back to reference Corbin JM, Strauss AL: Experiencing body failure and a disrupted self image. Unending Work and Care: Managing Chronic Illness at Home. Edited by: Corbin J, Strauss AL. 1988, San Francisco, Calif: Jossey-Bass, 49-67. Corbin JM, Strauss AL: Experiencing body failure and a disrupted self image. Unending Work and Care: Managing Chronic Illness at Home. Edited by: Corbin J, Strauss AL. 1988, San Francisco, Calif: Jossey-Bass, 49-67.
30.
go back to reference Lambert BL, Street RL, Cegala DJ, Smith H, Kurtz S, Schofield T: Provider-patient communication, patient-centered care, and the mangle of practice. Health Commun. 1997, 9: 27-43. 10.1207/s15327027hc0901_3.CrossRef Lambert BL, Street RL, Cegala DJ, Smith H, Kurtz S, Schofield T: Provider-patient communication, patient-centered care, and the mangle of practice. Health Commun. 1997, 9: 27-43. 10.1207/s15327027hc0901_3.CrossRef
31.
go back to reference Charmaz K: Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn. 1987, 5: 168-195.CrossRef Charmaz K: Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn. 1987, 5: 168-195.CrossRef
32.
go back to reference Gallagher M, Hares T, Spencer J, Bradshaw C, Webb I: The nominal group technique: a research tool for general practice?. Fam Pract. 1993, 10: 76-81. 10.1093/fampra/10.1.76.CrossRefPubMed Gallagher M, Hares T, Spencer J, Bradshaw C, Webb I: The nominal group technique: a research tool for general practice?. Fam Pract. 1993, 10: 76-81. 10.1093/fampra/10.1.76.CrossRefPubMed
33.
go back to reference Miller D, Shewchuk R, Elliot TR, Richards S: Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers. Diabetes Educ. 2000, 26: 305-310. 10.1177/014572170002600211. 312, 314CrossRefPubMed Miller D, Shewchuk R, Elliot TR, Richards S: Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers. Diabetes Educ. 2000, 26: 305-310. 10.1177/014572170002600211. 312, 314CrossRefPubMed
34.
go back to reference Jefferson WK, Zunker C, Feucht JC, Fitzpatrick SL, Greene LF, Shewchuk RM, Baskin ML, Walton NW, Phillips B, Ard JD: Use of the Nominal Group Technique (NGT) to understand the perceptions of the healthiness of foods associated with African Americans. Eval Program Plann. 2010, 33: 343-348. 10.1016/j.evalprogplan.2009.11.002.CrossRefPubMed Jefferson WK, Zunker C, Feucht JC, Fitzpatrick SL, Greene LF, Shewchuk RM, Baskin ML, Walton NW, Phillips B, Ard JD: Use of the Nominal Group Technique (NGT) to understand the perceptions of the healthiness of foods associated with African Americans. Eval Program Plann. 2010, 33: 343-348. 10.1016/j.evalprogplan.2009.11.002.CrossRefPubMed
35.
go back to reference Kleiner-Fisman G, Gryfe P, Naglie G: A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique. Park Dis. 2013, 2013: 974964- Kleiner-Fisman G, Gryfe P, Naglie G: A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique. Park Dis. 2013, 2013: 974964-
36.
go back to reference MacLachlan M: Identifying problems in community health promotion: an illustration of the Nominal Group Technique in AIDS education. J R Soc Health. 1996, 116: 143-148. 10.1177/146642409611600303.CrossRefPubMed MacLachlan M: Identifying problems in community health promotion: an illustration of the Nominal Group Technique in AIDS education. J R Soc Health. 1996, 116: 143-148. 10.1177/146642409611600303.CrossRefPubMed
37.
go back to reference Pastrana T, Radbruch L, Nauck F, Hover G, Fegg M, Pestinger M, Ross J, Krumm N, Ostgathe C: Outcome indicators in palliative care–how to assess quality and success, Focus group and nominal group technique in Germany. Support Care Cancer. 2010, 18: 859-868. 10.1007/s00520-009-0721-4.PubMedCentralCrossRefPubMed Pastrana T, Radbruch L, Nauck F, Hover G, Fegg M, Pestinger M, Ross J, Krumm N, Ostgathe C: Outcome indicators in palliative care–how to assess quality and success, Focus group and nominal group technique in Germany. Support Care Cancer. 2010, 18: 859-868. 10.1007/s00520-009-0721-4.PubMedCentralCrossRefPubMed
38.
go back to reference Pena A, Estrada CA, Soniat D, Taylor B, Burton M: Nominal group technique: a brainstorming tool for identifying areas to improve pain management in hospitalized patients. J Hosp Med. 2012, 7: 416-420. 10.1002/jhm.1900.CrossRefPubMed Pena A, Estrada CA, Soniat D, Taylor B, Burton M: Nominal group technique: a brainstorming tool for identifying areas to improve pain management in hospitalized patients. J Hosp Med. 2012, 7: 416-420. 10.1002/jhm.1900.CrossRefPubMed
39.
go back to reference Redman S, Carrick S, Cockburn J, Hirst S: Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique. Aust N Z J Public Health. 1997, 21: 250-256. 10.1111/j.1467-842X.1997.tb01695.x.CrossRefPubMed Redman S, Carrick S, Cockburn J, Hirst S: Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique. Aust N Z J Public Health. 1997, 21: 250-256. 10.1111/j.1467-842X.1997.tb01695.x.CrossRefPubMed
40.
go back to reference Singh JA: Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014, 20 (3): 172-174.PubMedCentralPubMed Singh JA: Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014, 20 (3): 172-174.PubMedCentralPubMed
42.
go back to reference Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood R: Patients' knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord. 2012, 13: 180-10.1186/1471-2474-13-180.PubMedCentralCrossRefPubMed Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood R: Patients' knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord. 2012, 13: 180-10.1186/1471-2474-13-180.PubMedCentralCrossRefPubMed
43.
go back to reference Covarrubias-Gomez A, Guevara-Lopez U, Haro-Valencia R, Alvarado-Suarez M: Importance of the obstructive sleep apnea disorder for perioperative medicine. Rev Med Inst Mex Seguro Soc. 2007, 45: 371-380.PubMed Covarrubias-Gomez A, Guevara-Lopez U, Haro-Valencia R, Alvarado-Suarez M: Importance of the obstructive sleep apnea disorder for perioperative medicine. Rev Med Inst Mex Seguro Soc. 2007, 45: 371-380.PubMed
44.
go back to reference Guevara-Lopez U, Ayala-Guerrero F, Covarrubias-Gomez A, Lopez-Munoz FJ, Torres-Gonzalez R: Effect of acute gouty arthritis on sleep patterns: a preclinical study. Eur J Pain. 2009, 13: 146-153. 10.1016/j.ejpain.2008.04.002.CrossRefPubMed Guevara-Lopez U, Ayala-Guerrero F, Covarrubias-Gomez A, Lopez-Munoz FJ, Torres-Gonzalez R: Effect of acute gouty arthritis on sleep patterns: a preclinical study. Eur J Pain. 2009, 13: 146-153. 10.1016/j.ejpain.2008.04.002.CrossRefPubMed
45.
go back to reference Westhovens R, Van der Elst K, Matthys A, Tran M, Gilloteau I: Sleep problems in patients with rheumatoid arthritis. J Rheumatol. 2014, 41: 31-40. 10.3899/jrheum.130430. Epub 2013/12/03CrossRefPubMed Westhovens R, Van der Elst K, Matthys A, Tran M, Gilloteau I: Sleep problems in patients with rheumatoid arthritis. J Rheumatol. 2014, 41: 31-40. 10.3899/jrheum.130430. Epub 2013/12/03CrossRefPubMed
46.
go back to reference Abbasi M, Yazdi Z, Rezaie N: Sleep disturbances in patients with rheumatoid arthritis. Niger J Med. 2013, 22: 181-186.PubMed Abbasi M, Yazdi Z, Rezaie N: Sleep disturbances in patients with rheumatoid arthritis. Niger J Med. 2013, 22: 181-186.PubMed
47.
go back to reference Fragiadaki K, Tektonidou MG, Konsta M, Chrousos GP, Sfikakis PP: Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol. 2012, 39: 60-62. 10.3899/jrheum.110617.CrossRefPubMed Fragiadaki K, Tektonidou MG, Konsta M, Chrousos GP, Sfikakis PP: Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol. 2012, 39: 60-62. 10.3899/jrheum.110617.CrossRefPubMed
48.
go back to reference Rees F, Jenkins W, Doherty M: Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis. 2013, 72: 826-830. 10.1136/annrheumdis-2012-201676.CrossRefPubMed Rees F, Jenkins W, Doherty M: Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis. 2013, 72: 826-830. 10.1136/annrheumdis-2012-201676.CrossRefPubMed
49.
go back to reference Lambert BL, Butin DN, Moran D, Zhao SZ, Carr BC, Chen C, Kizis FJ: Arthritis care: comparison of physicians' and patients' views. Semin Arthritis Rheum. 2000, 30: 100-110. 10.1053/sarh.2000.9203.CrossRefPubMed Lambert BL, Butin DN, Moran D, Zhao SZ, Carr BC, Chen C, Kizis FJ: Arthritis care: comparison of physicians' and patients' views. Semin Arthritis Rheum. 2000, 30: 100-110. 10.1053/sarh.2000.9203.CrossRefPubMed
50.
go back to reference Wells AF, MacDonald PA, Chefo S, Jackson RL: African American patients with gout: efficacy and safety of febuxostat vs allopurinol. BMC Musculoskelet Disord. 2012, 13: 15-10.1186/1471-2474-13-15.PubMedCentralCrossRefPubMed Wells AF, MacDonald PA, Chefo S, Jackson RL: African American patients with gout: efficacy and safety of febuxostat vs allopurinol. BMC Musculoskelet Disord. 2012, 13: 15-10.1186/1471-2474-13-15.PubMedCentralCrossRefPubMed
Metadata
Title
The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout
Author
Jasvinder A Singh
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2014
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4589

Other articles of this Issue 3/2014

Arthritis Research & Therapy 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.